Canada markets closed

Ceapro Inc. (CZO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5200-0.0300 (-5.45%)
At close: 03:52PM EST
Full screen
Previous Close0.5500
Open0.5600
Bid0.5200 x 0
Ask0.5600 x 0
Day's Range0.5200 - 0.5600
52 Week Range0.5000 - 0.9200
Volume40,000
Avg. Volume30,527
Market Cap40.397M
Beta (5Y Monthly)1.47
PE Ratio (TTM)26.00
EPS (TTM)0.0200
Earnings DateNov. 17, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th

    \- Access the event and schedule of presenting companies at virtualinvestorco.com -\- Live video webcast presentations of participating companies followed by interactive Q&A session -PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 /JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2022 Top Picks Conference January 25-27, 2022.

  • Simply Wall St.

    Ceapro's (CVE:CZO) Returns On Capital Not Reflecting Well On The Business

    Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

  • GlobeNewswire

    Ceapro Inc. Announces R&D Funding to Support PGX Technology Project

    – PGX Technology further recognized as a disruptive technology – Additional support paves the way for the manufacturing of pharmaceutical-grade yeast beta glucan (YBG) EDMONTON, Alberta, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced they are receiving advisory services and up to